About this trial
The goal of this multicenter retrospective observational study is to provide an inventory of the specific and non specific cord vocal lesions that can cause dysphonia in patients with systemic autoimmune diseases. The main question it aims to answer is:
* What are the main cord vocal lesions responsible for dysphonia in patients with a systemic autoimmune disease? * Is there a diagnosis delay regarding those lesions? * How are those lesions managed? Participants suffering from dysphonia in a context of a systemic autoimmune disease will be identified, with a review of their medical record.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18 years or older
With a systemic autoimmune disease : rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, primary Sjogren disease, sarcoidosis, vasculitis, myositis, Still disease, Sharp syndrome.
Suffering from dysphonia.
With a cord vocal/laryngeal lesion highlighted.
Disqualifiers
Patients under the age of 18 years
Dysphonia due to a cord vocal palsy related to a neurological condition or malignancy
History of cervical radiation
History of oro-tracheal intubation
Trial population
Patients aged 18 years or older suffering from dysphonia in a context of a systemic autoimmune disease.
Trial design
Case-only
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Nature of the cord vocal lesion responsible for dysphonia according to the physician (otorhinolaryngologist, rheumatologist or internist) from medical record
Diagnosis of the lesion responsible for dysphonia will be determined from medical record : medical report of the otorhinolaryngologist and/or laryngoscopy report if available or anatomopathological report in case of biopsy/surgery of the lesion. If no report from the otorhinolaryngologist is found in the record, then the reported diagnosis from the rheumatologist or the internist will be considered.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.